Floatz logo

849 assets in Breast Cancer

Therapeutic assets addressing Breast Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
cct303-406
Breast Cancer
Shanghai PerHum Therapeutics Co., Ltd.P1C (36)
Clr 125
Breast Cancer
Cellectar Biosciences, Inc.P1C (36)
Clsp-1025
Breast Cancer
Clasp Therapeutics, Inc.P1C (36)
Dat-2645
Breast Cancer
Danatlas Pharmaceuticals Co., LtdP1C (36)
Dpx-Survivac
Breast Cancer
Providence Health & ServicesP1C (36)
eg017
Breast Cancer
Changchun GeneScience Pharmaceutical Co., Ltd.P1C (36)
es2b-c001
Breast Cancer
ExpreS2ion BiotechnologiesP1C (36)
esr1 peptide vaccine
Breast Cancer
Herbert LyerlyP1C (36)
Fluoroglutamine (2S,4R)
Breast Cancer
Abramson Cancer Center at Penn MedicineP1C (36)
Fluorthanatrace F-18
Breast Cancer
University of PennsylvaniaP1C (36)
Fluzone Quadrivalent
Breast Cancer
Rush University Medical CenterP1C (36)
ft536
Breast Cancer
Fate TherapeuticsP1C (36)
ft836
Breast Cancer
Fate TherapeuticsP1C (36)
Gdc-0587
Breast Cancer
Genentech, Inc.P1C (36)
geh121224
Breast Cancer
GE HealthcareP1C (36)
Gnc-035
Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.P1C (36)
Gnc-077
Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.P1C (36)
Grt-C903
Breast Cancer
National Cancer Institute (NCI)P1C (36)
Grt-R904
Breast Cancer
National Cancer Institute (NCI)P1C (36)
her2 vaccine
Breast Cancer
Pravin T.P KaumayaP1C (36)
ic9-car.b7-h3 t cell therapy
Breast Cancer
UNC Lineberger Comprehensive Cancer CenterP1C (36)
Ide-161
Breast Cancer
IDEAYA BiosciencesP1C (36)
Idov-Immune
Breast Cancer
ViroMissile, Inc.P1C (36)
iks014
Breast Cancer
Iksuda Therapeutics Ltd.P1C (36)
il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells
Breast Cancer
Anusha KalbasiP1C (36)
il-15 enhanced engineered nk cells
Breast Cancer
M.D. Anderson Cancer CenterP1C (36)
im-1617
Breast Cancer
Immunome, Inc.P1C (36)
imm2520
Breast Cancer
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.P1C (36)
Iopofosine (¹³¹I)
Breast Cancer
Cellectar Biosciences, Inc.P1C (36)
kj015
Breast Cancer
Shanghai Bao Pharmaceuticals Co., Ltd.P1C (36)
Kk-Lc-1 Tcr-T Cells
Breast Cancer
Christian HinrichsP1C (36)
Kras Tcr-Transduced Pbl
Breast Cancer
National Cancer Institute (NCI)P1C (36)
Lncb74
Breast Cancer
NextCure, Inc.P1C (36)
Loxo-783
Breast Cancer
Eli Lilly and CompanyP1C (36)
L-Tryptophan, 1-(2-(Fluoro-18F)Ethyl)-
Breast Cancer
Barbara Ann Karmanos Cancer InstituteP1C (36)
Lutetium [177Lu] Bl-Arc001
Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.P1C (36)
Mbq-167
Breast Cancer
MBQ PharmaP1C (36)
Mesothelin-Targeted T Cells
Breast Cancer
Memorial Sloan Kettering Cancer CenterP1C (36)
MGC026
Breast Cancer
MacroGenicsP1C (36)
Milademetan
Breast Cancer
Institut CurieP2C (36)
Moma-313
Breast Cancer
MOMA TherapeuticsP1C (36)
ngm438
Breast Cancer
NGM Biopharmaceuticals, IncP1C (36)
ngm831
Breast Cancer
NGM Biopharmaceuticals, IncP1C (36)
Nuv-868
Breast Cancer
Nuvation Bio Inc.P1C (36)
Oct-598
Breast Cancer
Oscotec Inc.P1C (36)
Oki-219
Breast Cancer
OnKure, Inc.P1C (36)
Pacritinib
Breast Cancer
National University Hospital, SingaporeP1/2C (36)
pf-07224826
Breast Cancer
PfizerP1C (36)
P-Muc1C-Allo1 Car-T Cells
Breast Cancer
Poseida Therapeutics, Inc.P1C (36)
Pvx-410
Breast Cancer
Massachusetts General HospitalP1C (36)
Showing 701 to 750 of 849 assets
PreviousPage 15 of 17Next